Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-14
DOI
10.1038/s41598-018-21600-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds
- (2018) Peter Abadir et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways
- (2017) Hisato Shima et al. Scientific Reports
- Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure
- (2016) Qun Wei et al. Scientific Reports
- Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality
- (2015) Mahya Faghih et al. Aging-US
- Cellular and molecular mechanisms of repair in acute and chronic wound healing
- (2015) P. Martin et al. BRITISH JOURNAL OF DERMATOLOGY
- Best Reconstructive Techniques
- (2015) Brundha Balaraman et al. DERMATOLOGIC SURGERY
- Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1
- (2015) Manuela Schmidt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice
- (2015) Maria Kamber et al. Frontiers in Physiology
- Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts
- (2014) Elham Karimizadeh et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition
- (2014) Daniela Fraccarollo et al. BASIC RESEARCH IN CARDIOLOGY
- Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches
- (2014) Leonard Y. Kerwin et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Molecular and cellular basis of scleroderma
- (2014) Beate Eckes et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Collagen VII plays a dual role in wound healing
- (2013) Alexander Nyström et al. JOURNAL OF CLINICAL INVESTIGATION
- TSG-6 Released from Intradermally Injected Mesenchymal Stem Cells Accelerates Wound Healing and Reduces Tissue Fibrosis in Murine Full-Thickness Skin Wounds
- (2013) Yu Qi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Angiotensin-Converting Enzyme Inhibitor Enalapril Reduces Formation of Hypertrophic Scars in a Rabbit Ear Wounding Model
- (2013) Hakan Uzun et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Scar Revision Review
- (2012) J. Regan Thomas et al. Archives of Facial Plastic Surgery
- TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
- (2012) Rohan Samarakoon et al. CELLULAR SIGNALLING
- A Dual AP-1 and SMAD Decoy ODN Suppresses Tissue Fibrosis and Scarring in Mice
- (2012) Hong-Feng Yuan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis
- (2012) Mary E. Choi et al. SEMINARS IN NEPHROLOGY
- The Effect of Captopril on Impaired Wound Healing in Experimental Diabetes
- (2012) Ehsan Zandifar et al. International Journal of Endocrinology
- TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β
- (2011) Hiroaki Ikushima et al. CELL AND TISSUE RESEARCH
- Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report
- (2011) Wei-Qiang Tan et al. EXPERIMENTAL DERMATOLOGY
- Exploring anti-TGF-β therapies in cancer and fibrosis
- (2011) Lukas J. A. C. Hawinkels et al. GROWTH FACTORS
- Inhibitory machinery for the TGF-β family signaling pathway
- (2011) Susumu Itoh et al. GROWTH FACTORS
- TGF-β signaling in fibrosis
- (2011) Anna Biernacka et al. GROWTH FACTORS
- Unknown
- (2011) Gerd Gauglitz et al. MOLECULAR MEDICINE
- Hepatic Fibrosis and the Renin-Angiotensin System
- (2010) Ghulam Abbas et al. AMERICAN JOURNAL OF THERAPEUTICS
- Strategies for prevention of scars: what can we learn from fetal skin?
- (2010) Mohammad Reza Namazi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Signaling by members of the TGF-β family in vascular morphogenesis and disease
- (2010) Evangelia Pardali et al. TRENDS IN CELL BIOLOGY
- TGF-β and fibrosis in different organs — molecular pathway imprints
- (2009) Dirk Pohlers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammation and neuropeptides: the connection in diabetic wound healing
- (2009) Leena Pradhan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Transforming growth factor β as a therapeutic target in systemic sclerosis
- (2009) John Varga et al. Nature Reviews Rheumatology
- Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
- (2009) S. Inokuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of transforming growth factor-β superfamily signaling pathways in human disease
- (2008) Kelly J. Gordon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- TGF-β signaling in vascular biology and dysfunction
- (2008) Marie-José Goumans et al. CELL RESEARCH
- Antitransforming growth factor-β therapy in fibrosis: recent progress and implications for systemic sclerosis
- (2008) John Varga et al. CURRENT OPINION IN RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now